Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review

(2023) Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review. Case reports in dermatological medicine. p. 6353919. ISSN 2090-6463 (Print) 2090-6471 (Electronic) 2090-6463 (Linking)

Full text not available from this repository.

Abstract

Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases. Due to the popularity of metformin, clinicians need to be aware of uncommon drug reactions for proper diagnosis and treatment. Herein, we report a 43-year-old man with generalized bullous lesions with a positive dechallenge-rechallenge test diagnosed as metformin-induced generalized bullous fixed-drug eruption. Metformin dosage was stopped and lesions were treated with topical clobetasol propionate and oral prednisolone and cyclosporine-A. After a 6-month follow-up, he was well without any relapsing episodes.

Item Type: Article
Page Range: p. 6353919
Journal or Publication Title: Case reports in dermatological medicine
Journal Index: Pubmed
Volume: 2023
Identification Number: https://doi.org/10.1155/2023/6353919
ISSN: 2090-6463 (Print) 2090-6471 (Electronic) 2090-6463 (Linking)
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/27668

Actions (login required)

View Item View Item